Transcription Factor Networks derived from Breast Cancer Stem Cells control the immune response in the Basal subtype (2017)
- Authors:
- USP affiliated authors: ANDRADE, JURANDYR MOREIRA DE - FMRP ; MUGLIA, VALDAIR FRANCISCO - FMRP ; TIEZZI, DANIEL GUIMARÃES - FMRP
- Unidade: FMRP
- DOI: 10.1038/s41598-017-02761-6
- Subjects: NEOPLASIAS MAMÁRIAS; CÉLULAS-TRONCO; FATORES DE TRANSCRIÇÃO; METÁSTASE NEOPLÁSICA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Scientific Reports
- ISSN: 2045-2322
- Volume/Número/Paginação/Ano: v.7, art. 2851, 2017
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
SILVEIRA, W. A. da et al. Transcription Factor Networks derived from Breast Cancer Stem Cells control the immune response in the Basal subtype. Scientific Reports, v. 7, 2017Tradução . . Disponível em: https://doi.org/10.1038/s41598-017-02761-6. Acesso em: 31 mar. 2026. -
APA
Silveira, W. A. da, Palma, P. V. B., Sicchieri, R. D., Villacis, R. A. R., Mandarano, L. R. M., Oliveira, T. M. G., et al. (2017). Transcription Factor Networks derived from Breast Cancer Stem Cells control the immune response in the Basal subtype. Scientific Reports, 7. doi:10.1038/s41598-017-02761-6 -
NLM
Silveira WA da, Palma PVB, Sicchieri RD, Villacis RAR, Mandarano LRM, Oliveira TMG, Antonio HMR, Andrade JM de, Muglia VF, Rogatto SR, Theillet C, du Manoir S, Tiezzi DG. Transcription Factor Networks derived from Breast Cancer Stem Cells control the immune response in the Basal subtype [Internet]. Scientific Reports. 2017 ;7[citado 2026 mar. 31 ] Available from: https://doi.org/10.1038/s41598-017-02761-6 -
Vancouver
Silveira WA da, Palma PVB, Sicchieri RD, Villacis RAR, Mandarano LRM, Oliveira TMG, Antonio HMR, Andrade JM de, Muglia VF, Rogatto SR, Theillet C, du Manoir S, Tiezzi DG. Transcription Factor Networks derived from Breast Cancer Stem Cells control the immune response in the Basal subtype [Internet]. Scientific Reports. 2017 ;7[citado 2026 mar. 31 ] Available from: https://doi.org/10.1038/s41598-017-02761-6 - Development of new formulations of biologics: expectations, immunogenicity, and safety for subcutaneous trastuzumab
- Recurrence and survival after neoadjuvant chemotherapy for locally advanced cervical cancer is dependent on the pathological response
- Expression of hypoxia-inducible factor 1-'alfa' and vascular endothelial growth factor-C in locally advanced breast cancer patients
- Volume of breast tissue excised during breast-conserving surgery in patients undergoing preoperative systemic therapy
- Mouse renal 4T1 cell engraftment as a model to study the influence of hypoxia in breast cancer progression
- Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer
- ABCG2 is a potential marker of tumor-initiating cells in breast cancer
- Evolving concepts in breast lobular neoplasia and invasive lobular carcinoma, and their impact on imaging methods
- Clinical criteria as predictive factors of response to primary hormone therapy in locally advanced breast cancer
- Genetic profile analysis of tumor stem cells in locally advanced breast cancer
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
002912794.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
